本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Amneal Pharmaceuticals, Inc.

8.33
-0.0600-0.72%
盘前8.28-0.0500-0.60%09:08 EDT
成交量:146.68万
成交额:1,218.19万
市值:26.11亿
市盈率:-197.86
高:8.38
开:8.31
低:8.23
收:8.39
数据加载中...
2025/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/08

重要事件披露

Form 8-K - Current report
2025/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/02

重要事件披露

Form 8-K - Current report
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/07

重要事件披露

Form 8-K - Current report
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/28

重要事件披露

Form 8-K - Current report
2025/01/15

重要事件披露

Form 8-K - Current report
2025/01/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]